Novavax, Inc. (NVAX)
7.46
-0.36
(-4.66%)
USD |
NASDAQ |
Jul 24, 16:00
7.50
+0.04
(+0.54%)
After-Hours: 20:00
Novavax Gross Profit Margin (Quarterly) : 78.00% for March 31, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 78.00% |
| December 31, 2025 | 82.87% |
| September 30, 2025 | 71.90% |
| June 30, 2025 | 94.05% |
| March 31, 2025 | 97.93% |
| December 31, 2024 | 40.81% |
| September 30, 2024 | 30.40% |
| June 30, 2024 | 91.33% |
| March 31, 2024 | 48.00% |
| December 31, 2023 | 48.90% |
| September 30, 2023 | 47.09% |
| June 30, 2023 | 86.98% |
| March 31, 2023 | 73.33% |
| December 31, 2022 | 49.14% |
| September 30, 2022 | 39.70% |
| June 30, 2022 | -49.41% |
| March 31, 2022 | 96.88% |
| December 31, 2021 | 98.35% |
| September 30, 2021 | 0.00% |
| June 30, 2021 | 0.00% |
| March 31, 2021 | 0.00% |
| December 31, 2020 | 0.00% |
| September 30, 2020 | 0.00% |
| June 30, 2020 | 0.00% |
| March 31, 2020 | 0.00% |
| Date | Value |
|---|---|
| December 31, 2019 | 0.00% |
| September 30, 2019 | 0.00% |
| June 30, 2019 | 0.00% |
| March 31, 2019 | 0.00% |
| December 31, 2018 | 0.00% |
| September 30, 2018 | 0.00% |
| June 30, 2018 | 0.00% |
| March 31, 2018 | 0.00% |
| December 31, 2017 | 0.00% |
| September 30, 2017 | 0.00% |
| June 30, 2017 | 0.00% |
| March 31, 2017 | 0.00% |
| December 31, 2016 | 0.00% |
| September 30, 2016 | 0.00% |
| June 30, 2016 | 0.00% |
| March 31, 2016 | 0.00% |
| December 31, 2015 | 72.05% |
| September 30, 2015 | 57.90% |
| June 30, 2015 | 80.80% |
| March 31, 2015 | 75.10% |
| December 31, 2014 | 57.81% |
| September 30, 2014 | 50.97% |
| June 30, 2014 | 38.22% |
| March 31, 2014 | 59.51% |
| December 31, 2013 | 70.24% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Moderna, Inc. | -160.7% |
| Pfizer Inc. | 66.67% |
| Agenus, Inc. | 98.27% |
| Fate Therapeutics, Inc. | -124.6% |
| Recursion Pharmaceuticals, Inc. | -289.2% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -7.28% |
| Return on Invested Capital | -53.94% |
| Profit Margin (Quarterly) | -6.80% |
| Operating Margin (Quarterly) | -7.22% |
| Return on Net Operating Assets | -23.34% |